Concepedia

Dugyala Raju

DR

Statistics

Publications

4

Citations

479

H-Index

4

Active since

2020

Affiliations

Bharat Biotech (India)(Current)

SRM Institute of Science and Technology

Nizam's Institute of Medical Sciences

Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences

All India Institute of Medical Sciences

Dugyala Raju is an author at Bharat Biotech (India) specializing in immunology, vaccination, and immunization.

Publications per year

2020–2022

4

Publications

4

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial

Raches Ella, Siddharth Reddy, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 365 citations · Full text

, , +17

Persisting antibody responses to Vi polysaccharide–tetanus toxoid conjugate (Typbar TCV®) vaccine up to 7 years following primary vaccination of children < 2 years of age with, or without, a booster vaccination

Krishna Mohan Vadrevu, Dugyala Raju, Sandhya Rani et al. · Vaccine · 2021 · 42 citations · Full text

, , +17

Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report

Raches Ella, Siddharth Reddy, Harsh Jogdand et al. · medRxiv · 2020 · 38 citations · Full text

, , +17

Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants

Krishna Mohan Vadrevu, Brunda Ganneru, Siddharth Reddy et al. · Scientific Reports · 2022 · 34 citations · Full text

, , +17

1–4 of 4